ATORVASTATIN CALCIUM
- Product NDC
- 70518-2843
- 11-digit product format
- 705182843
- Labeler code
- 70518
- Product ID
- 70518-2843_d76fec73-8973-d108-e053-2995a90a1392
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA205945
- Marketing category
- ANDA
- Marketing start
- 2020-08-20
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2843-0 | 70518284300 | 28 TABLET, FILM COATED in 1 BLISTER PACK (70518-2843-0) | 2020-08-20 | 0000-00-00 | No | No | Current |